... risk behaviors such as smoking and obesity are associated with lower awareness of the Prostate Specific Antigen (PSA), which could lead to a lower likelihood of undergoing actual prostate cancer ...
... risk behaviours such as smoking and obesity are associated with lower awareness of the Prostate Specific Antigen (PSA), which could lead to a lower likelihood of undergoing actual prostate cancer ...
Although widespread Prostate-Specific-Antigen (PSA) testing has undoubtedly decreased prostate cancer ... 849 men (122 with and 727 without prostate cancer) with serial PSA measurements . Researchers ...
... of digital rectal exam (DRE), prostate-specific antigen (PSA) testing, repeat biopsy and ... for appropriately selected patients with low-risk prostate cancer appears to be safe, durable and associated ...
... with family histories of prostate cancer could benefit from a baseline prostate-specific antigen (PSA) reading to determine their probability of developing the disease. Researchers from Northwestern ...
... cholesterol may also help you manage your prostate- specific antigen level. New data explores the relationship between low-density lipoprotein (LDL) cholesterol and PSA prior ...
... since it is higher-grade, potentially metastatic prostate cancers that are the real cause for clinical concern. ... race, family history of prostate cancer, baseline prostate-specific antigen (PSA) levels ...
... , a new study shows. The study included 27 patients who had increased levels of prostate specific antigen after being treated with high-intensity focused ultrasonic (HIFU) ablation; 18 of these ...
... year his cancer count, or prostate specific antigen (PSA), was at a high level -- an indicator ... Endowed Chair for Cancer Research, director of the Prostate Cancer Research Program at the OHSU Cancer ...
... Cell, also suggest that men with SPINK1–related prostate cancers tend to have a quicker recurrence of the disease ... 65.
Current tests for prostate cancer include prostate-specific antigen (PSA) blood ...
... ETS gene fusions occur in 40%-80% of prostate-specific antigen (PSA)-screened ... Analysis (COPA), that identifies outlier oncogenes in a specific subset of cancer cases. Using this methodology to examine ...
... use a risk predictor that includes variables like stage, Gleason score and serum levels of prostate-specific antigen. "However, this method is only accurate about 70 percent of the time, which is not ...
... could provide information about how patients are responding to therapy earlier than other markers such as prostate-specific antigen (PSA) or time-to-disease progression," he said. "We have observed ...
... hormone, due to rising levels of prostate-specific antigen with no evidence of metastasis. For patients who ... works in two ways.
"By using hormone therapy in prostate cancer you can help enhance your ...
... researchers are exploring the effectiveness of using androgen depletion therapy in men with rising levels of prostate specific antigen, a potential precursor to prostate cancer. The authors concluded ...
